CBD Health Claims Spur FDA Warning & Product Seizure Threats

CBD Health Claims Spur FDA Warning & Product Seizure Threats

The 2018 Farm Bill gave cannabis businesses around the country a legal path to market and sell hemp and hemp-derived products. Despite the groundbreaking law, several regulatory uncertainties remain. The FDA has been a source of many of those uncertainties, but recent...
Stillwater Labs Accredited to ISO/IEC 17025

Stillwater Labs Accredited to ISO/IEC 17025

The American Association for Laboratory Accreditation (A2LA) announced earlier this month the accreditation of Stillwater Laboratories, Inc. to ISO/IEC 17025. Based in Olney, Montana, Stillwater Labs is the first laboratory A2LA has accredited to the ISO 17025...
Sweden Joins Italy In Path To Defining CBD Oil Regulations

Sweden Joins Italy In Path To Defining CBD Oil Regulations

The highest court in Sweden has weighed in on the novel food, and the darling of the Swiss marketplace, CBD conversation. Further, it has done so in a move that seems predetermined to push the so-far escalating novel food debate EU-wide. Along, of course, with what...
FDA Sends Warning Letters to Curaleaf

FDA Sends Warning Letters to Curaleaf

Curaleaf Hemp, a well-known and publicly traded cannabis company, made headlines this week for all the wrong reasons. The US Food & Drug Administration (FDA) sent a warning letter to Curaleaf President Joseph Lusardi for making unsubstantiated health claims and...